InsiderTrades.com logo
The AI stock to buy right now
From StockEarnings   |   Ad
There are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy?
Click Here to Get the AI Stock Name

Bradley Hargreaves Biography and Net Worth

Major Shareholder of Cell MedX
  • Phone
  • Website


Presently, Bradley Hargreaves is Operations Director & Principal at XC Velle Institute, Inc. and Director, VP-Technology & Operations at Cell MedX Corp., Director, VP-Technology & Operations at Cell MedX (Canada) Corp. (a subsidiary of Cell MedX Corp.).

How do I contact Bradley S. Hargreaves?

The corporate mailing address for Mr. Hargreaves and other Cell MedX executives is 123 W Nye Ln Ste 446, CARSON CITY, NV 89706-0899, United States. Cell MedX can also be reached via phone at (844) 238-2692. Learn More on Bradley S. Hargreaves' contact information.

Has Bradley S. Hargreaves been buying or selling shares of Cell MedX?

Bradley S. Hargreaves has not been actively trading shares of Cell MedX during the last ninety days. Most recently, Bradley S. Hargreaves sold 35,000 shares of the business's stock in a transaction on Thursday, April 22nd. The shares were sold at an average price of $0.26, for a transaction totalling $9,100.00. Learn More on Bradley S. Hargreaves' trading history.

Bradley S. Hargreaves Insider Trading History at Cell MedX

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/22/2021Sell35,000$0.26$9,100.00
4/20/2021Sell97,342$0.25$24,335.50
4/16/2021Sell23,500$0.22$5,170.00
4/6/2021Sell20,000$0.23$4,600.00
See Full Table

Bradley S. Hargreaves Buying and Selling Activity at Cell MedX

This chart shows Bradley S Hargreaves's buying and selling at Cell MedX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cell MedX Company Overview

Cell MedX logo
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.03
Low: $0.02
High: $0.05

2 Week Range

Now: $0.02
Low: $0.00
High: $0.93

Volume

40 shs

Average Volume

25,585 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
The AI stock to buy right now
From StockEarnings   |   Ad
There are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy?
Click Here to Get the AI Stock Name